Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...

Patients express mixed feelings about AI in healthcare, favoring its use for documentation and administrative tasks while ...

Nanoscope Therapeutics formed the Vision Advisory Committee to guide its efforts in retinal care, focusing on retinitis pigmentosa and Stargardt disease. The VAC, chaired by Dr. SriniVas Sadda, ...